Samuel A. Shelburne, M.D., Ph.D.

Samuel A. Shelburne, M.D., Ph.D., is a Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on the clinical microbiology of hospital-acquired infections, antimicrobial resistance, and infection control, particularly concerning pathogenic bacteria and Candida species in critically ill and immunocompromised patients. Recent work includes identifying gut microbiome signatures that differentiate infectious from non-infectious neutropenic fever in leukemia, characterizing Candida auris colonization, and defining genomic determinants of carbapenem and ceftazidime-avibactam resistance in Escherichia coli bloodstream infections. His publications appear in leading journals, including JAMA, Clinical Infectious Diseases, and mSystems.